ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,369.07
-0.56%
Dow Jones
39,806.05
-0.17%
Gold vs US Dollar
2,388.08
-1.38%
Brent Oil
81.99
-0.55%
Bitcoin
70,518.32
0.55%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Alkermes PLC (ALKS) Share Price

ALKS Alkermes PLC

24.54
0.20 (0.82%)
Last Updated: 16:33:12
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Alkermes PLC NASDAQ:ALKS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.20 0.82 24.54 24.53 24.55 24.84 24.34 24.41 315,350 15:33:12   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.66B 355.76M 2.1293 11.62 4.13B
 Type  Size  Price  Time  Units 
 9 3 24.545 15:33:11 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALKS News
14/05/202421:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
14/05/202412:00PRNUSAlkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
14/05/202412:00PRNUSAlkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
02/05/202412:00PRNUSAlkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
01/05/202412:00PRNUSAlkermes plc Reports First Quarter 2024 Financial Results
24/04/202412:00PRNUSAlkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
17/04/202421:00PRNUSAlkermes to Report First Quarter Financial Results on May 1, 2024
Period
Draw mode
Data Downloads for ALKS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Alkermes PLC Articles